Classification of Alzheimer's disease stages from magnetic resonance images using deep learning
Source check: Source checked. Not independent scientific confirmation.
Finding: Primary PeerJ article/PDF Methods and Results report CNN/transfer-learning image classification on ADNI/OASIS MRI with test performance by stage; scope is retrospective benchmark classification.
Technology: Deep CNN family predicts Alzheimer stage labels from MRI. Results are strongest for AD/control and weaker for adjacent MCI groups; no clinical deployment claim.
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
- AI contribution
- Deep CNN family predicts Alzheimer stage labels from MRI. Results are strongest for AD/control and weaker for adjacent MCI groups; no clinical deployment claim.
- Test and result
- Deep CNN family predicts Alzheimer stage labels from MRI. Results are strongest for AD/control and weaker for adjacent MCI groups; no clinical deployment claim.
- Limitation / still unknown
- Primary PeerJ article/PDF Methods and Results report CNN/transfer-learning image classification on ADNI/OASIS MRI with test performance by stage; scope is retrospective benchmark classification. The source does not establish benefits beyond the reported evaluation.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://peerj.com/articles/cs-1490.pdf
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: other. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.